Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

1,816 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    News From Second & State: September 13, 2019

    An on-time budget in June brought a quiet summer in Harrisburg, but the dog days are behind us and it's time to get ready for the legislature's return.
    United StatesEnvironment
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    4 Potential FDA Drug Approvals To Watch In 2025

    2025 is expected to mark a pivotal moment for the pharmaceutical industry, as numerous noteworthy drug products are poised to seek FDA approval.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
Article

The 340B Drug Pricing Program: Navigating Challenges In Healthcare Access

Established in 1992, the 340B Drug Pricing Program was designed to enable eligible healthcare providers, called covered entities, to purchase outpatient drugs at significant discounts.
United StatesFood, Drugs, Healthcare, Life Sciences
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney
  • Article

    Trump vs. Biden – How The 2020 Election Will Impact The Healthcare Sector

    Healthcare was always poised to be a defining issue in the 2020 presidential election.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    US Government Seeks Mandatory Cyber & Ransomware Reporting Requirements

    In the wake of recent high-profile cyber and ransomware attacks, Congress and the Biden administration have joined forces, in an increasingly rare show of bipartisanship.
    United StatesGovernment, Public Sector
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    USCIS Issues New Version Of Form I-9 Employment Eligibility Verification Form

    Earlier this year, United States Citizenship and Immigration Services (USCIS) announced a new version of Form I-9 Employment Eligibility Verification with an edition date of October 21, 2019.
    United StatesImmigration
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    USPTO Publishes Updated Guidance For Determining Obviousness

    The United States Patent and Trademark Office (USPTO) has published updated Guidance for determining obviousness based on the U.S. Supreme Court's ruling in KSR Int'l Co. v. Teleflex Inc., 550 U.S.
    United StatesIntellectual Property
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    President Trump Announces New Reciprocal Tariffs

    On July 30, 2025, the President announced that imports from India would begin to face a 25% reciprocal tariff rate
    United StatesInternational Law
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Supreme Court Expands Protections For Confidential Commercial And Financial Information Turned Over To Government Agencies

    FOIA generally requires the disclosure of information that the federal government collects, subject to certain exemptions.
    United StatesLitigation, Mediation & Arbitration
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Antitrust Action Against Potential Collusion Impacting Labor Markets Will Not Be Quarantined During The COVID-19 Pandemic

    The Antitrust Division of the U.S. Department of Justice and the Federal Trade Commission recently issued a joint statement cautioning employers against taking advantage of the COVID-19 crisis by colluding with competitors on hiring, wages, or other conditions of employment.
    United StatesAntitrust/Competition Law
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    FTC Fails To Halt Hospital Merger – For Now

    Afederal judge has ruled against the Federal Trade Commission's (FTC) bid for a preliminary injunction to stop Novant Health, Inc. (Novant), a Winston-Salem...
    United StatesAntitrust/Competition Law
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Texas HEMP Legislation Set For Public Hearing On Monday, April 7, 2025

    As discussed in our prior post, Texas, like many state legislatures, is currently considering heightened regulation of the hemp derived cannabinoid market.
    United StatesCannabis & Hemp
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Updates On Florida And Texas Hemp Regulation

    For the second year, the Florida Legislature has not been able to pass legislation pertaining to the further regulation of hemp-derived cannabinoid products.
    United StatesCannabis & Hemp
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Will The Commonwealth Of Massachusetts Amend Laws On Adult-Use Recreational Marijuana?

    Prohibitionists are hoping to offer Massachusetts voters the opportunity to reverse the Commonwealth's regulations governing the cultivation, manufacture, distribution...
    United StatesCannabis & Hemp
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    FCC Proposes Additional TCPA Calling, Texting Restrictions

    At its June 8, 2023 Open Meeting, the Federal Communication Commission (FCC) adopted a Notice of Proposed Rulemaking (Notice) aimed at clarifying and strengthening consumers' ability...
    United StatesConsumer Protection
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Worth Another Look: 2020-21 Budget, Schools That Teach

    Once again, Governor Wolf's annual budget address was highlighted by three themes: "Schools that Teach," "Jobs that Pay" and Government that Works."
    United StatesConsumer Protection
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    COVID-19: Section 139 Employer-Provided Tax-Free Disaster Relief Benefits

    In light of the exigency and uncertainty caused by the COVID-19 pandemic, employers should look to Section 139 as a favorable and efficient mechanism to provide tax-free supplemental assistance to employees.
    United StatesCoronavirus (COVID-19)
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    More COVID-19 Paid Sick Leave In California For 2022

    This past Saturday, February 19, 2022, a new COVID-19 Supplemental Paid Sick Leave (SPSL) law took effect in California. Employers now must display a required notice or...
    United StatesCoronavirus (COVID-19)
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Operating At Warp Speed: Key Takeaways From COVID-19 Clinical Trials

    As we enter the latest wave of the novel coronavirus attack, we are only nine months into a public health war that is proving difficult and lengthy.
    United StatesCoronavirus (COVID-19)
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Colleges And Universities Explore Merger Opportunities As Industry Consolidates

    Colleges and universities throughout the country are facing a perfect financial storm as they struggle to deal with the continuing pressures of COVID-19, challenges in federal and state funding, and a diminishing pool of student applicants.
    United StatesCorporate/Commercial Law
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Showing 981–1000 of 1816 results

    Previous
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics